title: INFECTIOUS DISEASE. Vaginal microbiome affects HIV risk.
authors.forename: Jon
authors.initials: J
authors.lastname: Cohen
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D019380:Anti-HIV Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007249:Inflammation / Q000382:microbiology; D007778:Lactobacillus / Q000302:isolation & purification; D064307:Microbiota / Q000187:drug effects / Q000502:physiology*; D065129:Pre-Exposure Prophylaxis; D018720:Prevotella / Q000302:isolation & purification; D012306:Risk; D013019:South Africa / Q000453:epidemiology; D000068698:Tenofovir / Q000008:administration & dosage; D014621:Vagina / Q000382:microbiology*; D014622:Vaginal Creams, Foams, and Jellies / Q000008:administration & dosage
chemical_list: D019380:Anti-HIV Agents; D014622:Vaginal Creams, Foams, and Jellies; D000068698:Tenofovir